SKF107457, an innovative biomedicine, presents an efficacious treatment modality for an array of ailments. Functioning as an influential and specific stimulator of the glucagon-like peptide-1 receptor (GLP-1R), this product proffers a promising avenue for managing afflictions like type 2 diabetes, obesity, and neurodegenerative disorders. Its intricate mode of operation encompasses augmenting insulin release contingent upon glucose levels and fostering satiety, ultimately culminating in enhanced glycemic regulation and profound reductions in body weight.
CAT No: R2077
CAS No:126333-28-6
Chemical Name:methyl (2S)-2-[[(2S)-2-[[(4S,5S)-5-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]propanoyl]amino]-4-hydroxy-6-phenylhexanoyl]amino]-3-methylbutanoyl]amino]-3-methylbutanoate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More